ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.[citation needed]
A phase I trial in 118 patients showed safety in humans.[1]
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.